Rhode Island Biotechnology Company Develops Tularemia Vaccine
EpiVax, Inc, a leader in genome-derived vaccines, announced today that it has developed a promising tularemia vaccine candidate (TuliVaxTM) that confers protective immunity. Francisella tularensis is...
View ArticleEffective Tularemia Vaccine may be Developed Using Immune System Quirk
A unique quirk in the way the immune system fends off bacteria called Francisella tularensis has been discovered by immunologists at the University of Pittsburgh School of Medicine and Children's...
View ArticleEffective Tularemia Vaccine may be Developed Using Immune System Quirk
A unique quirk in the way the immune system fends off bacteria called Francisella tularensis has been discovered by immunologists at the University of Pittsburgh School of Medicine and Children's...
View Article
More Pages to Explore .....